These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 9886707)

  • 1. Clinical epidemiology of heart failure: public and private health burden.
    McMurray JJ; Petrie MC; Murdoch DR; Davie AP
    Eur Heart J; 1998 Dec; 19 Suppl P():P9-16. PubMed ID: 9886707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Modern therapy of cardiac insufficiency].
    Stojsić D; Jelkić N
    Med Pregl; 1999; 52(3-5):113-24. PubMed ID: 10518395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence, clinical characteristics, quality of life, and prognosis of patients with congestive heart failure and isolated left ventricular diastolic dysfunction.
    Badano LP; Albanese MC; De Biaggio P; Rozbowsky P; Miani D; Fresco C; Fioretti PM
    J Am Soc Echocardiogr; 2004 Mar; 17(3):253-61. PubMed ID: 14981424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diabetes mellitus, left ventricular dysfunction and congestive heart failure].
    Tarantini L; Di Lenarda A; Velussi M; Faggiano P; Comaschi M; Faglia E; Maggioni AP
    Ital Heart J Suppl; 2004 Aug; 5(8):605-15. PubMed ID: 15554015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and risk factors of asymptomatic first-dose hypotension with angiotensin-converting enzyme inhibitors in chronic heart failure due to systolic dysfunction.
    Thanikachalam S; Manchanda SC
    Indian Heart J; 2003; 55(2):167-71. PubMed ID: 12921333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Left ventricular systolic dysfunction and atrial fibrillation in older people in the community--a need for screening?
    Ho SF; O'Mahony MS; Steward JA; Burr ML; Buchalter M
    Age Ageing; 2004 Sep; 33(5):488-92. PubMed ID: 15271642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical features and prognosis associated with a preserved left ventricular systolic function in a large cohort of congestive heart failure outpatients managed by cardiologists. Data from the Italian Network on Congestive Heart Failure.
    Tarantini L; Faggiano P; Senni M; Lucci D; Bertoli D; Porcu M; Opasich C; Tavazzi L; Maggioni AP
    Ital Heart J; 2002 Nov; 3(11):656-64. PubMed ID: 12506524
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of heart failure: effective strategies to combat the growing epidemic.
    Fonarow GC; Horwich TB
    Rev Cardiovasc Med; 2003; 4(1):8-17. PubMed ID: 12684599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue angiotensin-converting enzyme inhibitors for the prevention of cardiovascular disease in patients with diabetes mellitus without left ventricular systolic dysfunction or clinical evidence of heart failure: a pooled meta-analysis of randomized placebo-controlled clinical trials.
    Saha SA; Molnar J; Arora RR
    Diabetes Obes Metab; 2008 Jan; 10(1):41-52. PubMed ID: 18095949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. beta-Blocker therapy in heart failure.
    Doughty RN
    Heart Fail Monit; 2000; 1(1):2-7. PubMed ID: 12634875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology of heart failure and left ventricular systolic dysfunction after acute myocardial infarction: prevalence, clinical characteristics, and prognostic importance.
    Weir RA; McMurray JJ; Velazquez EJ
    Am J Cardiol; 2006 May; 97(10A):13F-25F. PubMed ID: 16698331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Epidemiology and risk factors for heart failure in the elderly].
    Rengo F; Leosco D; Iacovoni A; Rengo G; Golino L; Borgia F; De Lisa G; Beneduce F; Senni M
    Ital Heart J; 2004 Dec; 5 Suppl 10():9S-16S. PubMed ID: 15712508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and aldosterone antagonists in the prevention of atrial and ventricular arrhythmias.
    Makkar KM; Sanoski CA; Spinler SA
    Pharmacotherapy; 2009 Jan; 29(1):31-48. PubMed ID: 19113795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Left ventricular hypertrophy and heart failure in women.
    Agabiti-Rosei E; Muiesan ML
    J Hypertens Suppl; 2002 May; 20(2):S34-8. PubMed ID: 12183849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asymptomatic left ventricular dysfunction: an overlooked part of the continuum of heart failure.
    Misra A; Diwan A; Mann DL; Deswal A
    Heart Fail Monit; 2002; 3(2):42-8. PubMed ID: 12634879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diastolic heart failure.
    Frigerio M; Aguggini G
    Ital Heart J; 2004 Jun; 5 Suppl 6():48S-54S. PubMed ID: 15185915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost of depression in Europe.
    Sobocki P; Jönsson B; Angst J; Rehnberg C
    J Ment Health Policy Econ; 2006 Jun; 9(2):87-98. PubMed ID: 17007486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients with congestive heart failure and chronic kidney disease.
    Berger AK; Duval S; Manske C; Vazquez G; Barber C; Miller L; Luepker RV
    Am Heart J; 2007 Jun; 153(6):1064-73. PubMed ID: 17540211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and pharmacologic management of chronic heart failure associated with left ventricular systolic dysfunction.
    Parra D; Marshall R; Soisson K
    Lippincotts Prim Care Pract; 1999; 3(3):316-32. PubMed ID: 10711133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cellular and physiologic effects of beta blockers in heart failure.
    Sabbah HN
    Clin Cardiol; 1999 Oct; 22 Suppl 5():V16-20. PubMed ID: 10526699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.